Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.

[1]  M. Ulanova,et al.  Invasive Haemophilus influenzae Disease Caused by Non – Type b Strains in Northwestern Ontario , Canada , 2002 – 2008 , 2009 .

[2]  M. Ulanova,et al.  Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  D. Fisman,et al.  Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. , 2009, Vaccine.

[4]  C. Whitney,et al.  Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. , 2008, Vaccine.

[5]  S. Halperin,et al.  Ongoing Control of Haemophilus influenzae Type B Infections in Canadian Children, 2004–2007 , 2008, The Pediatric infectious disease journal.

[6]  Simon G Thompson,et al.  Why and how Sources of Heterogeneity Should be Investigated , 2008 .

[7]  S. Halperin,et al.  Invasive Infections Caused by Haemophilus influenzae Serotypes in Twelve Canadian IMPACT Centers, 1996–2001 , 2007, The Pediatric infectious disease journal.

[8]  M. Dworkin,et al.  The Changing Epidemiology of Invasive Haemophilus influenzae Disease, Especially in Persons ⩾65 Years Old , 2007 .

[9]  J. Wylie,et al.  Invasive Haemophilus influenzae in Manitoba, Canada, in the Postvaccination Era , 2006, Journal of Clinical Microbiology.

[10]  J. Campos,et al.  Analysis of Invasive Haemophilus influenzae Infections after Extensive Vaccination against H. influenzae Type b , 2004, Journal of Clinical Microbiology.

[11]  M. Melbye,et al.  Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine. , 2004, Vaccine.

[12]  J. Campos,et al.  Antibiotic resistance and clinical significance of Haemophilus influenzae type f. , 2003, The Journal of antimicrobial chemotherapy.

[13]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[14]  R. Singleton,et al.  Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. , 2000, JAMA.

[15]  H. Peltola.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. , 2000, Clinical microbiology reviews.

[16]  J. Sciberras.  Invasive Haemophilus influenzae serotype B surveillance in Ontario--documenting the progression towards elimination. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[17]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[18]  E. Anis,et al.  Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. , 1999, Vaccine.

[19]  P. Aavitsland,et al.  Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. , 1999, The Journal of infectious diseases.

[20]  M. Lipsitch,et al.  Vaccination against colonizing bacteria with multiple serotypes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Barbour,et al.  Conjugate vaccines and the carriage of Haemophilus influenzae type b. , 1996, Emerging infectious diseases.

[22]  M. Farley,et al.  Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Crook,et al.  Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide‐CRM197 (HbOC) conjugate vaccine , 1993, The Pediatric infectious disease journal.

[24]  M. Leinonen,et al.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. , 1991, The Journal of infectious diseases.

[25]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .